We split six vials four ways and posted them
Duplicate submissions under different names test within-laboratory repeatability, which is a different quantity from between-laboratory reproducibility.
Sunniva Ørstavik
Page 11 of 12 of this archive, newest first.
Archive — page 11
237 piecesGermany caps dulaglutide prescribing to 24 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
The slide that was not in the abstract
Reported from the sessions, and from the two hours afterwards.
From the floor in Zhuhai: 23 posters, one theme
Reported from the sessions, and from the two hours afterwards.
A shortage listing ends. 19 pharmacies now have a business model and no legal basis for it.
The document is four pages. Three of them are about dates.
Blind duplicates: what happens when a laboratory does not know it is being watched
Two years ago we ran an anonymised version of this comparison and promised a named one. This is it, with every method printed in full.
The slide that was not in the abstract
Reported from the sessions, and from the two hours afterwards.
A shortage listing ends. 18 pharmacies now have a business model and no legal basis for it.
The document is four pages. Three of them are about dates.
From the floor in Shenzhen: 10 posters, one theme
Reported from the sessions, and from the two hours afterwards.
Portugal caps tirzepatide prescribing to 5 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
The badge is about a sample. The listing is about a product.
The Journal does not treat a badge as evidence and states so wherever it reports one.
A shortage listing ends. 6 pharmacies now have a business model and no legal basis for it.
The document is four pages. Three of them are about dates.
South Africa caps semaglutide prescribing to 8 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
Ireland caps liraglutide prescribing to 22 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
The slide that was not in the abstract
Reported from the sessions, and from the two hours afterwards.
A shortage listing ends. 6 pharmacies now have a business model and no legal basis for it.
The document is four pages. Three of them are about dates.
Inspectors cite the relabeller trading as Vantris Bio over sterility assurance
The observation that closes a facility is rarely the dramatic one.
The slide that was not in the abstract
Reported from the sessions, and from the two hours afterwards.
The slide that was not in the abstract
Reported from the sessions, and from the two hours afterwards.
A shortage listing ends. 8 pharmacies now have a business model and no legal basis for it.
The document is four pages. Three of them are about dates.